Coherus BioSciences, Inc. (NASDAQ:CHRS)

CAPS Rating: 5 out of 5

Results 1 - 1 of 1

Recs

0
Member Avatar usubanas (99.73) Submitted: 1/13/2015 12:18:05 PM : Outperform Start Price: $22.43 CHRS Score: +2.20

Good management with lots of experience. Seems to be under the radar, but biosimilars time is finally coming...

Results 1 - 1 of 1

Featured Broker Partners


Advertisement